Controversial Study on Puberty Blockers Shelved

NEW YORK, USA: A $10 million research study on the mental health impact of puberty blockers on trans youth claims to have been stopped from publication – a move that’s sparking heated debate both in scientific and advocacy communities. It is alleged that a figurehead in medicine made the decision, prompting immediate responses to those who suggested the study demonstrated bias in the promotion of certain stories and others who responded that the action taken was ethical and scientific.

Controversy at the Study Conclusion

Puberty blockers do not have any measurable improvements in any kind of mental health endpoints for participants, thus increasing the debate over the transgender healthcare practices.

Outcome of the Study: A Mixed Bag
The multimillion-dollar study, designed to measure whether puberty blockers help, concludes that there is no kind of mental well-being improvement in time for the trans-children. These latest findings are in contradiction to previous studies that had proved somewhat earlier that there has been an improvement in both reduced anxiety and depression endpoints.The results contradict what’s long been known in transgender care,” said an expert who is aware of the report. But the decision to withhold the study has raised questions about whether science is being subjected to ideological agendas.

Ethics or Bias? A Divided Response

The move not to publish the study has evoked shock and criticism within the medical circles, inquiring the role behind hiding the data. Some argued that the

Image Source